VR Logo

Landos Biopharma Inc. (LABP) download report


Healthcare | Biotechnology & Pharma Research

Landos Biopharma Inc. (LABP) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases.

IPO Date: 04-Feb-2021

Principal Financial Officer, Pres, CEO & Director: Mr. Timothy M. Mayleben M.B.A.

Advisor: Dr. Josep Bassaganya-Riera DVM, Ph.D.

Listing: NASDAQ: LABP

Country: United States

Headquarters: Blacksburg, VA

Website: https://landosbiopharma.com

Key Facts

Market cap: $28.90 Mln

Revenue (TTM): $0.02 Mln

Earnings (TTM): $-43.47 Mln

Cash: $73.80 Mln

Total Debt: $0.03 Mln

Insider's Holding: 24.48%

Liquidity: Low

52 Week range: $0.55 - 16.17

Shares outstanding: 40,254,900

Stock Performance

Time Period Landos Biopharma (LABP) S&P BSE Sensex* S&P Small-Cap 600*
YTD-84.84-9.08-19.53
1 month1.10-4.69-9.69
3 months-59.56-9.57-16.90
1 Year-93.770.91-17.67
3 Years--10.375.77
5 Years--11.365.69
10 Years--11.759.74
As on 30-Jun-2022 *As on 01-Jul-2022